Utama › Kanser Metastatik › Wilayah Columbia › Washington
Kajian klinikal Kanser Metastatik di Washington, DC
43 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauh
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of ASP3082 in Adults With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Mengambil pesertaFasa 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Mengambil pesertaFasa 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi jauh
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi jauh
- Maryland Oncology Hematology, P.A., Largo · 11 mi jauh
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Mengambil pesertaFasa 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Mengambil pesertaFasa 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mi jauh
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Mengambil pesertaFasa 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
Mengambil pesertaFasa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Mengambil pesertaFasa 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Mengambil pesertaFasa 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mi jauh
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Mengambil pesertaFasa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Mengambil pesertaFasa 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Mengambil pesertaFasa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Mengambil pesertaFasa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Mengambil pesertaFasa 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Mengambil pesertaFasa 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mi jauh
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Mengambil pesertaFasa 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Mengambil pesertaFasa 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Mengambil pesertaFasa 3
- American Oncology Partners, P.A., Bethesda · 7 mi jauh
Studying TAK-243 in Patients With Advanced Cancer
Mengambil pesertaFasa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauh
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Mengambil pesertaFasa 2/3
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi jauh
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Mengambil pesertaFasa 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Mengambil pesertaFasa 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Mengambil pesertaFasa 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Mengambil pesertaFasa 1
- National Cancer Institute, Bethesda · 7 mi jauh
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Mengambil pesertaFasa 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Mengambil pesertaFasa 1
- American Oncology Partners of Maryland, Bethesda · 7 mi jauh
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Mengambil pesertaFasa 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi jauh
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi jauh
Kajian Kanser Metastatik di bandar lain
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Dallas, TX42 kajian
- Seattle, WA39 kajian
Kajian lain di Washington
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil55 kajian
- Kanser Payudara46 kajian
- Kanser Paru-paru41 kajian
- Kanser Prostat38 kajian
- Obesiti33 kajian
- Kanser Kolorektal29 kajian
- Penyakit Kardiovaskular28 kajian
- Kanser Pundi Kencing26 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Ovari23 kajian
- Limfoma23 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.